Evidence check: WeightLoss | SLIM DNA-Test in the context of menopause

The SLIM DNA-Test for weight loss during menopause is marketed as a personalized nutrition tool, but the scientific evidence is weak. While certain genetic variants (e.g., FTO, MC4R) are associated with appetite regulation and metabolism, their effect sizes are small, and most evidence comes from GWAS, not interventional trials. Menopause involves significant hormonal shifts (estrogen decline) that alter fat distribution and basal metabolic rate – a DNA test cannot capture these dynamic changes. MyBody-X tests are not diagnostic; they only indicate genetic predispositions. Without concurrent lifestyle modifications (diet, exercise, stress management), the test's utility is limited. The evidence level is best described as 'marketing' or 'unclear'. For meaningful weight management during menopause, consult a healthcare professional rather than relying solely on genetic testing.